10 /100
LOW RISK
Score updated Jul 13, 2026

NDAQ — Nasdaq, Inc. Dilution Risk Tracker

Track NDAQ dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NDAQ — Get alerts when the score changes →

As of July 13, 2026, Nasdaq, Inc. (NDAQ) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Nasdaq, Inc. has a market capitalization of $52.32B, 565.54M shares outstanding, 1094 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NDAQ.
🔔 Track NDAQ — Get forecast alerts →

💹 Market Data

Market Cap$52.32B
Shares Outstanding565.54M
Float503.11M
Cash$769.00M
Debt$8.96B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.6% shares (2026Q1 vs prior)
1094 institutional holders · 550.46M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 62.48M shares
#2 INVESTOR AB 58.38M shares
#3 BlackRock, Inc. 38.17M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.33M
Days to Cover1.5
% of Float1.9%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2010
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NDAQ Shareholders

Nasdaq, Inc. (NDAQ) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for NDAQ shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NDAQ in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NDAQ alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NDAQ Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NDAQ — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NDAQ
📊 NDAQ FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NDAQ Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.